Key facts
- Tuned (Therapeutic Devices)’s last known valuation is $17.0M (Dec 2024).
- It has raised $7.7M; the latest was Early Stage VC ($1.0M) in Dec 2024.
- Notable investors include Plug and Play Tech Center, Vast Ventures, Bridge Investments, Distributed Ventures, Elements Health Investors — 8 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 8 names
- ·Watchlist + deal alerts for Tuned (Therapeutic Devices)
- ·The full record, as it builds
Funding rounds
No funding rounds for Tuned (Therapeutic Devices) are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Tuned (Therapeutic Devices)
Provider of preventive digital hearing health services intended for broader health benefit programs. The company offers online hearing screenings, virtual consultations with licensed audiologists, personalized care plans, transparent pricing, integration tools for benefits administrators, and curated lists of vetted hearing solutions catering to early intervention, tinnitus support, and workplace hearing wellness, enabling employers and health plans to include comprehensive hearing care as part of employee health benefits and support long-term hearing health outcomes.
- Sector
- Healthcare
- HQ
- New York, NY, United States
- Founded
- 2020
- Employees
- 20
- Website
- tunedcare.com/
- Ownership
- Privately Held (backing)
Tuned (Therapeutic Devices) doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Tuned (Therapeutic Devices) shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Tuned (Therapeutic Devices) in its N-PORT filings yet. We sweep new filings monthly.